Hallmarks of Resistance to Immune-Checkpoint Inhibitors. - Karasarides M; Cogdill AP; Robbins PB; Bowden M; Burton EM; Butterfield LH; Cesano A; Hammer C; Haymaker CL; Horak CE; McGee HM; Monette A; et al. (Cancer immunology research, 2022)